Select a community
ALS including PLS and PMA
Find out more about the PatientsLikeMe
ALS Community
Home > Community Treatment Reports > Lithobid (lithium carbonate) Treatment Report
What is Lithobid?

LITHOBID® (lithium carbonate) is an extended-release formulation containing 300mg of lithium carbonate. LITHOBID is indicated in the treatment of manic episodes of Bipolar Disorder. Read more...Click to read more below

JDS Pharmaceuticals, LLC's Lithobid site

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Slow my ALS progress 2 0
Other 1 0

Mouse over the table for more information

Dosages

  300 mg daily 900 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Lithobid (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 50% Did not seem to work: 50%
Side effects too severe
1 50% Side effects too severe: 50%

See all 2 patients who’ve stopped taking Lithobid

Duration See details about how long patients take this treatment ▼

Currently Taking Lithobid

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
0

Stopped Taking Lithobid

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Research:
Lithium & ALS

See how ALS patients taking lithium are doing in real-time by viewing FRS scores before and after starting lithium. Easily compare individual dosages and blood levels, and filter results by a rich set of patient characteristics.

Icon_bullet_arrow Research: Lithium & ALS

Report created on November 21, 2009.